| John William Kieffer, MD | |
|
Unit 3215, Apo, AE 09094-3215 | |
| (637) 146-2273 | |
| Not Available |
| Full Name | John William Kieffer |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | Unit 3215, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073906459 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 0101260992 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John William Kieffer, MD Unit 3215, Apo, AE 09094-3215 Ph: () - | John William Kieffer, MD Unit 3215, Apo, AE 09094-3215 Ph: (637) 146-2273 |
News Archive
The scientific tools are not yet available to build a comprehensive map of the activity in the most complicated 3 pounds of material in the world - the human brain, scientists say in a newly published article.
People with prediabetes were significantly more likely to suffer a heart attack, stroke or other major cardiovascular event when compared with those who had normal blood sugar levels, according to research being presented at the American College of Cardiology's 70th Annual Scientific Session.
A new technical report from the American Academy of Pediatrics (AAP) and the National Center on Sleep Disorders Research (National Heart, Lung, and Blood Institute, NIH) says that although sleepiness is rather common in this age group, pediatricians should pay special attention to patients who exhibit evidence of excessive sleepiness because it could indicate an underlying medical or mental health condition.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced the results of a study evaluating the activity of elesclomol against acute myeloid leukemia (AML) cell lines and primary leukemic blast cells from AML patients, presented at the Annual Meeting of the American Society of Hematology (ASH) in New Orleans.
› Verified 9 days ago
Dr. Talitha Moon, DO, MPH Preventive Medicine Medicare: Medicare Enrolled Practice Location: Sudlager 301, Apo, AE 92249 Phone: 314-590-2402 | |
Dr. Timothy D. Robinette, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 86th Mdg Unit 3215, Apo, AE 09094 Phone: 314-480-4675 | |
Dr. Donald Walter Robinson, DO Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Hhc, Asg-ku, Attn: Medical, Apo, AE 09366 Phone: 706-239-9678 | |
Dr. Jeffrey Michael Diffenderfer, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-542-3080 | |
Dr. Sonia Leigh Molchan, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: Unit 3215, Apo, AE 09094 Phone: 637-146-2609 | |
Dr. Admirado Adolfo Luzuriaga, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 86 Mdg Unit 3215, Apo, AE 09094 Phone: 004-963-71462609 |